CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Similar to OP9/L cells, the primary ECs in KOBA-bearing mice showed increased CD34 expression, which is characteristic of new angiogenesis in human CML [35], implying that these ECs are derived in part from MSCs via transdifferentiation [36] [37].